Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrazine in Amyotrophic Lateral Sclerosis
NCT04950647Phase 2Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
A Phase 2 trial of nitroketazine in amyotrophic lateral sclerosis (ALS), sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
nitroketazine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04950647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04950647.